From: circ-ANXA7 facilitates lung adenocarcinoma progression via miR-331/LAD1 axis
Univariate analysis | Multivariate analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | p value | |
Age | 0.985 | 0.759–1.496 | 0.659 | |||
Gender | 0.645 | 0.452–1.228 | 0.598 | |||
Smoking history | 1.269 | 0.884–1.549 | 0.195 | |||
Histologic subtype | 0.799 | 0.224 − 0.120 | 0.344 | |||
TNM stage | 3.466 | 2.359–4.988 | 0.001 | 2.498 | 1.701–3.273 | 0.009** |
Tumor size(cm) | 2.215 | 1.498–2.970 | 0.059 | 1.765 | 0.921–2.431 | 0.198 |
Lymph metastasis | 2.278 | 1.959–2.995 | 0.040 | 1.745 | 1.207–2.301 | 0.039* |
Recurrence status | 3.478 | 2.214–4.987 | 0.002 | 3.048 | 2.364–3.699 | 0.001*** |
LAD1 expression | 2.639 | 1.759–3.648 | 0.019 | 2.455 | 1.904–2.959 | 0.025* |